TP53 c.715_737del ;(p.N239Efs*17)

Variant ID: 17-7577543-CATGCCGCCCATGCAGGAACTGTT-C

NM_000546.5(TP53):c.715_737del;(p.N239Efs*17)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations.

Oncotarget
Demuth, Christina C; Winther-Larsen, Anne A; Madsen, Anne Tranberg AT; Meldgaard, Peter P; Sorensen, Boe Sandahl BS
Publication Date: 2018-07-24

Variant appearance in text: N/A
PubMed Link: 30123427
Variant Present in the following documents:
View BVdb publication page



Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.

Scientific Reports
Hou, Helei H; Yang, Xiaonan X; Zhang, Jinping J; Zhang, Zhe Z; Xu, Xiaomei X; Zhang, Xiaoping X; Zhang, Chuantao C; Liu, Dong D; Yan, Weihua W; Zhou, Na N; Zhu, Hongmei H; Qian, Zhaoyang Z; Li, Zhuokun Z; Zhang, Xiaochun X
Publication Date: 2017-11-06

Variant appearance in text: N/A
PubMed Link: 29097733
Variant Present in the following documents:
View BVdb publication page



Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma.

Plos One
Végran, Frédérique F; Rebucci, Magali M; Chevrier, Sandy S; Cadouot, Muriel M; Boidot, Romain R; Lizard-Nacol, Sarab S
Publication Date: 2013

Variant appearance in text: TP53: 715_737del
PubMed Link: 23359294
Variant Present in the following documents:
  • Main text
  • pone.0055103.pdf
View BVdb publication page